Monday, 9 November 2020

Wall Street rallies on coronavirus vaccine trial results

Wall Street rallies on coronavirus vaccine trial results

The S&P 500 and the Dow rallied sharply but closed shy of their records on Monday as investors bet that a full economic reopening was finally in sight following the first positive data from a late-stage COVID-19 vaccine trial.

Biden says vaccine approval process must be guided by science

President-elect Joe Biden on Monday said a coronavirus vaccine approval process must be guided by science so the public can have confidence it is safe and effective, warning that the United States is still facing a very dark winter and that a vaccine likely won't be available for months.

Corporate America says it is ready to work with Biden

Corporate America says it is ready to work with President-elect Joe Biden, hoping for quick action on a new round of COVID-19 relief and infrastructure spending.

Pfizer vaccine trial success signals breakthrough in pandemic battle

Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus that has killed over a million people and battered the world's economy.

Highlights: Pfizer COVID-19 vaccine news delivers hope around the globe

News that Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results renewed hope on Monday among world leaders, scientists and global investors that the battle against a pandemic that has killed over a million people could be won.

U.S. judge to hear dispute over Google DOJ antitrust lawsuit protective order

A U.S. judge said on Monday he will consider arguments in a disputed order related to the protection of confidential information in the Justice Department's antitrust lawsuit filed against Alphabet Inc's Google LLC unit.

S&P and Dow advance, Treasury yields soar on potential vaccine

The S&P 500 and the blue-chip Dow indices followed world equity indexes higher and U.S. Treasury yields surged on Monday, as progress in the development of a coronavirus vaccine sparked a surge of optimism that the global economy will stage a solid recovery as life returns to normal,

EU 'regrettably' hits U.S. with tariffs, seeks better Biden ties

The European Union will impose tariffs on up to $4 billion of U.S. imports in retaliation for U.S. subsidies for Boeing , but said on Monday it was hopeful of an improvement in trade ties under U.S. President-elect Joe Biden.

U.S. voices disappointment on EU move to impose tariffs

U.S. Trade Representative Robert Lighthizer on Monday expressed disappointment about the European Union's decision to impose tariffs on U.S. planes and other goods, but refrained from threatening to respond with further U.S. action.

U.S. still faces possible default wave, asset declines due to pandemic: Fed

The United States may still face a wave of debt defaults and "significant declines" in asset prices because of the coronavirus pandemic and recession, the Federal Reserve warned on Monday, in a stark reminder the economy is far from out of the woods.

Related Videos

S&P 500, Dow hit all-time highs on vaccine news

SoftBank posts profit, but tech investments sting

2020ibmSec_Artboard_1reutersAd.jpg
Sponsored by IBM: Risk Quantification

Explore how putting security risk in financial terms helps your executives make decisions, connecting security risk management with business strategy.

LEARN HOW TO QUANTIFY RISK